Data / Drug companies / Granule, for suspension
Companies that list granule, for suspension products: 23 companies and 35 products in the FDA NDC directory
The FDA National Drug Code Directory lists 35 products that are granule, for suspension products from 23 companies. The ten largest listers hold 60.0% of them, and the newest started marketing on July 7, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 23
- Products
- 35
- Drugs by generic name
- 10
- Main marketing category
- New drug applications (NDA)
Companies that list granule, for suspension products
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ani Pharmaceuticals, Inc. | 3 | granule, for suspension | Generic drugs (ANDA) | March 25, 2019 |
| Astellas Pharma Inc. | 2 | granule, for suspension | Drugs for further processing | May 24, 2018 |
| Astellas Pharma US, Inc. | 2 | granule, for suspension | New drug applications (NDA) | May 24, 2018 |
| Aurobindo Pharma Limited | 2 | granule, for suspension | Generic drugs (ANDA) | June 8, 2007 |
| Azurity Pharmaceuticals, Inc. | 2 | granule, for suspension | New drug applications (NDA) | April 18, 2011 |
| Cmic Cmo Co., LTD. | 2 | granule, for suspension | Drugs for further processing | May 24, 2018 |
| Genentech, Inc. | 2 | granule, for suspension | New drug applications (NDA) | May 30, 2025 |
| NorthStar Rx LLC | 2 | granule, for suspension | Generic drugs (ANDA) | June 8, 2007 |
| Pharmacia & Upjohn Company LLC | 2 | granule, for suspension | New drug applications (NDA) | April 18, 2000 |
| Rising Pharma Holdings, Inc. | 2 | granule, for suspension | Generic drugs (ANDA) | June 8, 2007 |
| Wilshire Pharmaceuticals, Inc. | 2 | granule, for suspension | New drug applications (NDA) | September 28, 2016 |
| American Health Packaging | 1 | granule, for suspension | Generic drugs (ANDA) | August 20, 2023 |
| Ascend Laboratories, LLC | 1 | granule, for suspension | Generic drugs (ANDA) | July 7, 2025 |
| Camber Pharmaceuticals, Inc. | 1 | granule, for suspension | Generic drugs (ANDA) | October 31, 2022 |
| IntraBio Inc | 1 | granule, for suspension | New drug applications (NDA) | September 24, 2024 |
| Janssen Pharmaceuticals, Inc. | 1 | granule, for suspension | New drug applications (NDA) | December 1, 2021 |
| Merck Sharp & Dohme LLC | 1 | granule, for suspension | New drug applications (NDA) | February 18, 2020 |
| Merck Sharp & Dohme LLC | 1 | granule, for suspension | New drug applications (NDA) | December 20, 2013 |
| Mylan Pharmaceuticals Inc. | 1 | granule, for suspension | Authorized generics (NDA) | April 4, 1977 |
| Patheon France S.a.s. | 1 | granule, for suspension | Drugs for further processing | September 24, 2024 |
| Patheon Inc. | 1 | granule, for suspension | Drugs for further processing | December 1, 2021 |
| Patheon Pharmaceuticals Inc. | 1 | granule, for suspension | Drugs for further processing | December 20, 2013 |
| Shionogi Pharma Co., Ltd. | 1 | granule, for suspension | Drugs for further processing | July 23, 2020 |
Drugs most often listed
| Drug | Products here | Companies listing it |
|---|---|---|
| Tacrolimus | 2 | 35 |
| Linezolid | 3 | 28 |
| Rivaroxaban | 2 | 24 |
| Cefpodoxime proxetil | 6 | 11 |
| Colestipol hydrochloride | 2 | 10 |
| Erythromycin ethylsuccinate | 7 | 8 |
| Fidaxomicin | 1 | 6 |
| Raltegravir | 1 | 6 |
| Baloxavir marboxil | 2 | 2 |
| Levacetylleucine | 1 | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.